Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Connect 2025" conference has been added to ResearchAndMarkets.com's offering.
The Global Clinical Trials Connect 2025 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.
This conference intends to focus on the global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.
The summit will facilitate an invaluable networking opportunities with decision makers and focus on real case studies, insightful presentations and round tables.
Key Highlights
- Patient Recruitment and Site selection
- Innovative trial designs
- Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
- Patient centric clinical trials
- Making Patient Engagement a Reality
- New innovations in Patient Recruitment planning and execution on a clinical trial
- Outsourcing strategies and models
- Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
- Streamlined IRT development process
- Pharmacovigilance & Clinical Trials
- Post-Clinical Trial closed communities
- How to future proof your clinical operations
- Diversity and Inclusion in Clinical Trials
- Implementing Risk Based Monitoring
- Streamlining R&D and lower costs in clinical trials
- Adaptive Trial Model
- Clinical Trial Auditing
- Real World Clinical Trial Strategies
- Data Quality & Technology
- Clinical Data Strategy & Analytics
- Electronic Data Capture (EDC) Systems
- Decentralised Clinical Trials
- Clinical Technology and Driving Innovation
- M-Health, Wearable and Consumer Technology
- Big-Data, IoT and Artificial Intelligence in Clinical trials
- Blockchain technology for improving clinical research quality
Who Should Attend:
This event is designed for senior level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO's, Investigative Sites, Solution provider and Government institutions.
Attendees includes VPs, GMs, Directors, Heads and Managers of:
- Clinical Trials
- Clinical Study Management
- Clinical Operations
- Clinical Research
- Patient Organizations
- Patient Recruitment
- Outsourcing
- Vendor Management
- Site Management
- Site Monitoring
- Clinical Pharmacology
- Clinical Data Management
- Risk Monitoring
- EDC
- Clinical/Digital Innovation
- Clinical Design/Protocol design/ Strategy makers
- Clinical Research Sites
- CROs and CMOs
- Hospitals/ Associations
- Regulatory affairs
Agenda:
Day 1
08:00 Registration & Refreshments
08:50 Welcome Address & Chairperson's opening remarks
ng Efficiency through Streamlined Clinical Trials
09:00 Tactical and Strategic Use of AI in Clinical Trials
09:30 Integrating Blockchain into clinical research
10:00 Innovating with AI: digital transformations for clinical research
10:30 Ensuring Compliance and Inspection Readiness Through Effective Risk Management
11:00 Business Card Exchange with Morning Coffee/Tea & Discussion
11:20 Forging Successful Global Research Partnership in Southeast Asia - Universiti Malaya Medical Centre's Experience
11:50 Advancing Patient Safety Through Inclusive Clinical Trials: Harnessing Real-World Data Directly from Source
12:20 Digital Transformation: Developing and deploying a digital authoring platform across the value chain
12:45 Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths
13:35 Increasing diversity in clinical trials in the UK: Results from a nationally representative survey
14:00 Patient Involvement and Patient Reported Outcomes. Does it make a difference?
14:30 End-to-End management of critical quality factors across a vaccine study/program
15:00 From EHR to Sponsor - harnessing electronic health records in clinical research
15:30 Recharge with Tea or Coffee While Networking
15:50 Panel discussion: Critical Success Factors while Planning for Site Selection and Patient Recruitment
16:20 The Role of Investigator-Initiated Trials in Leveraging Real-World Evidence
16:50 Sponsor centric to Patient centric framework - Improving patient recruitment & enhancing their involvement
17:20 Panel Discussion: The Future of Patient-Centricity in Clinical Trials - Embedding a patient-centric approach to clinical trial design
17:50 Interactive Breakout Round Table Discussion
18:20 Chairperson's Closing Remark
18:30 Networking Drinks Session - Unwind with Evening Drinks and Engaging Conversations
Day 2
08:30 Registration & Refreshments
08:50 Welcome Address & Chairperson's opening remarks
Shaping the Future with Innovative Trials
09:00 Personalized Clinical Trials Framework: Considerations for implementation from a patient centricity perspective
09:30 Roche Rater Academy: An enterprise wide approach to developing a rater training lifecycle to improve rater data quality, productivity and inclusivity for an improved customer experience enabled through a strategic supplier partnership
10:00 New opportunities for patient recruitment and diversity - Conducting clinical trials in the MENA region
10:30 Data-Enabled Recruitment to Clinical Trials and How Real-World Data Can Enhance Clinical Trial Outcomes and Safety Monitoring
11:00 Business Card Exchange with Morning Coffee/Tea & Discussion
11:20 Empowering Clinical Research with Artificial Intelligence: Unlocking the Value of Real-World Data
11:45 Planning and Placement: A recipe for research delivery success
12:15 Smart use of GenAI, NLP and ML in Oncology Clinical Trials
12:40 Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths
13:30 How clinical trials can utilise predictive ai to simulate a trial to predict its probability of success, and optimise the variables to increase success probability!
13:55 Quality considerations for the use of Real World Evidence in clinical development
14:25 Weighing and evaluating the outsourcing approach that is right for you
14:55 EU PEARL, platform trials
15:25 Recharge with Tea or Coffee While Networking
15:45 Africa's role in reducing clinical delays
16:15 Interpretation and Impact of Real-World Clinical Data
16:45 Panel Discussion: Leveraging Big Data and AI in the Era of Tech-Driven Clinical Trials: Opportunities and Ethical Dilemmas
17:15 Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
17:40 Chairperson's Closing Remark
Speakers
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Richardus Vonk
VP, Head of Oncology Data Analytics and Statistical Sciences
Bayer AG
Tim Williams
Head of Interventional Research - CPRD
Medicines and Healthcare products Regulatory Agency
Jose Manuel Cervera Grau
Executive Director
Eli Lilly and Company
Dex Bilkic
Director, Alliance Management
AstraZeneca
Prof. Dr. Ho Gwo Fuang
Consultant clinical oncologist
Clinical Investigation Centre, UMMC
Nadir Ammour
Global Lead, Clinical Innovation & External Partnership
Sanofi
Regine Buffels
Principal Global Medical Affairs Director
Hoffmann-La Roche
Meelis Lootus
Member of IEEE Novel Biomarkers for Decentralised Clinical Trials Working Group
IEEE
Jennifer Eyerman
Clinical Trial Partner, Clinical Operations, Research and Early Development
Roche
Craig Elliott
Director Strategic Alliance and Sourcing
Merck Group
Martin Gibson
Chief Medical Officer
NorthWest EHealth
Rebecca West
Associate Director leading Global Health
Ipsos
Viraj Rajadhyaksha
Area Medical Director
AstraZeneca
Andrew Gray
Director, QA Clinical Therapeutic Area Head
Johnson & Johnson
Sophie Wintrich
Patient Advocacy Connector
Patient Co-Next
Tina Barton
Chief Operating Officer
Emerging Markets Quality Trials (eMQT)
Shalom Lloyd
Co-Founder & Chief Strategy Officer
Emerging Markets Quality Trials (eMQT)
Pauline Frank
Chief Patient Connector
Patient Co-Next
Rebecca Jackson
Senior Manager, R&D IT, Enabling Innovation
Johnson & Johnson Technology
Miguel Valenzuela
Associate Director Clinical Operations - RBQM+
Alnylam Pharmaceuticals
Magali Traskine
Associate Director, Central Monitoring
GSK
Gabriel Maeztu
Co-Founder & President
IOMED
Jordi Guitart
Chief Executive Officer
Science4Tech
Saurabh Jain
Chief Executive Officer
TrialKey
Diane Driver
Head Program Delivery
UCB
Karen Matthews
Senior Business Development Manager
NIHR Research Delivery Network
Rasmus Hjorth
Head of communication
James Lind Care
Lukasz Wiech
Chief Medical Officer
European Clinical Trials Information Network
Rohan Simon
Associate Director - Business Development
Insights Research Organization & Solutions
Waheed Jowiya
Digitalisation Strategy Lead
Novo Nordisk
Louise Lind Skov
Head of Content Digitalisation
Novo Nordisk
Jane Reed
Director of Life Sciences NLP
Linguamatics
Lucy Campbell
Research Manager
King's College London
For more information about this conference visit https://www.researchandmarkets.com/r/xdxoom
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
